<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36291381</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Lactoferrin as Possible Treatment for Chronic Gastrointestinal Symptoms in Children with Long COVID: Case Series and Literature Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1446</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children9101446</ELocationID><Abstract><AbstractText>Long COVID is an emergent, heterogeneous, and multisystemic condition with an increasingly important impact also on the pediatric population. Among long COVID symptoms, patients can experience chronic gastrointestinal symptoms such as abdominal pain, constipation, diarrhea, vomiting, nausea, and dysphagia. Although there is no standard, agreed, and optimal diagnostic approach or treatment of long COVID in children, recently compounds containing multiple micronutrients and lactoferrin have been proposed as a possible treatment strategy, due to the long-standing experience gained from other gastrointestinal conditions. In particular, lactoferrin is a pleiotropic glycoprotein with antioxidant, anti-inflammatory, antithrombotic, and immunomodulatory activities. Moreover, it seems to have several physiological functions to protect the gastrointestinal tract. In this regard, we described the resolution of symptoms after the start of therapy with high doses of oral lactoferrin in two patients referred to our post-COVID pediatric unit due to chronic gastrointestinal symptoms after SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Universit&#xe0; Cattolica Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Universit&#xe0; Cattolica Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardinali</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory and Infectious Sciences, Universit&#xe0; del Sacro Cuore, 20123 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6095-9510</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Universit&#xe0; Cattolica Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario "Agostino Gemelli", IRCCS, Universit&#xe0; Cattolica Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory and Infectious Sciences, Universit&#xe0; del Sacro Cuore, 20123 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">lactoferrin</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">oral supplementation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36291381</ArticleId><ArticleId IdType="pmc">PMC9600357</ArticleId><ArticleId IdType="doi">10.3390/children9101446</ArticleId><ArticleId IdType="pii">children9101446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V., Meoli A., Chiopris G., Motta M., Skenderaj K., Grandinetti R., Bergomi A., Antodaro F., Zona S., Esposito S. Long COVID in Children and Adolescents. Life. 2022;12:285. doi: 10.3390/life12020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Gennaro L., De Rose C., Morello R., D&#x2019;Ilario F., Zampino G., Piazza M., Boner A.L., Iraci C., O&#x2019;Connell S., et al. Long-term outcomes of pediatric infections: From traditional infectious diseases to long COVID. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.  [(accessed on 6 October 2021)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pinto Pereira S., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., Bundgaard H., Palm P., Rotvig C., Vinggaard Christensen A. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child. Adolesc. Health. 2022;6:240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza M., Di Cicco M., Pecoraro L., Ghezzi M., Peroni D., Comberiati P. Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome. Biomolecules. 2022;12:556. doi: 10.3390/biom12040556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12040556</ArticleId><ArticleId IdType="pmc">PMC9024951</ArticleId><ArticleId IdType="pubmed">35454144</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Piazza M., Boner A.L., Bellanti J.A. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma. Proc. 2022;43:187&#x2013;193. doi: 10.2500/aap.2022.43.220018.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. 2022;376:1261&#x2013;1265. doi: 10.1126/science.add4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); London, UK: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L., Tripepi G., Naldi E., Aimati M., Santangeli S., Venditto F., Caldarelli M., Valenti P. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. J. Clin. Med. 2021;10:4276. doi: 10.3390/jcm10184276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184276</ArticleId><ArticleId IdType="pmc">PMC8469309</ArticleId><ArticleId IdType="pubmed">34575388</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottoni F., Giobbe G.G., Zambaiti E., Khalaf S., Sebire N.J., Curry J., De Coppi P., Gennari F. Intussusception and COVID-19 in Infants: Evidence for an Etiopathologic Correlation. Pediatrics. 2022;149:e2021054644. doi: 10.1542/peds.2021-054644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-054644</ArticleId><ArticleId IdType="pubmed">35322271</ArticleId></ArticleIdList></Reference><Reference><Citation>Presti S., Manti S., Parisi G.F., Papale M., Barbagallo I.A., Li Volti G., Leonardi S. Lactoferrin: Cytokine Modulation and Application in Clinical Practice. J. Clin. Med. 2021;10:5482. doi: 10.3390/jcm10235482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235482</ArticleId><ArticleId IdType="pmc">PMC8658270</ArticleId><ArticleId IdType="pubmed">34884183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattar E.H., Elrashdy F., Almehdar H.A., Uversky V.N., Redwan E.M. Natural resources to control COVID-19: Could lactoferrin amend SARS-CoV-2 infectivity? PeerJ. 2021;9:e11303. doi: 10.7717/peerj.11303.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.11303</ArticleId><ArticleId IdType="pmc">PMC8052957</ArticleId><ArticleId IdType="pubmed">33954061</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi G.F., Carota G., Castruccio Castracani C., Spampinato M., Manti S., Papale M., Di Rosa M., Barbagallo I., Leonardi S. Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature. Int. J. Mol. Sci. 2021;22:2465. doi: 10.3390/ijms22052465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052465</ArticleId><ArticleId IdType="pmc">PMC7957644</ArticleId><ArticleId IdType="pubmed">33671104</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto M., Di Rienzo L., B&#xf2; L., Boffi A., Ruocco G., Milanetti E. Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin. Front. Mol. Biosci. 2021;8:607443. doi: 10.3389/fmolb.2021.607443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.607443</ArticleId><ArticleId IdType="pmc">PMC7917183</ArticleId><ArticleId IdType="pubmed">33659275</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaziano R., Pistoia E.S., Campione E., Fontana C., Marino D., Favaro M., Pica F., Di Francesco P. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19. Eur. Rev. Med. Pharmacol. Sci. 2021;25:4174&#x2013;4184. doi: 10.26355/eurrev_202106_26061.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202106_26061</ArticleId><ArticleId IdType="pubmed">34156699</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagliola G., Spada E., Comberiati P., Peroni D.G. Could nutritional supplements act as therapeutic adjuvants in COVID-19? Ital. J. Pediatr. 2021;47:32. doi: 10.1186/s13052-021-00990-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-00990-0</ArticleId><ArticleId IdType="pmc">PMC7883952</ArticleId><ArticleId IdType="pubmed">33588905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrityunjaya M., Pavithra V., Neelam R., Janhavi P., Halami P.M., Ravindra P.V. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Front. Immunol. 2020;11:570122. doi: 10.3389/fimmu.2020.570122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.570122</ArticleId><ArticleId IdType="pmc">PMC7575721</ArticleId><ArticleId IdType="pubmed">33117359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruzel M.L., Zimecki M., Actor J.K. Lactoferrin in a Context of Inflammation-Induced Pathology. Front. Immunol. 2017;8:1438. doi: 10.3389/fimmu.2017.01438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01438</ArticleId><ArticleId IdType="pmc">PMC5681489</ArticleId><ArticleId IdType="pubmed">29163511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L., Cutone A., Lepanto M.S., Paesano R., Valenti P. Lactoferrin: A natural glycoprotein involved in Iron and inflammatory homeostasis. Int. J. Mol. Sci. 2017;18:1985. doi: 10.3390/ijms18091985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091985</ArticleId><ArticleId IdType="pmc">PMC5618634</ArticleId><ArticleId IdType="pubmed">28914813</ArticleId></ArticleIdList></Reference><Reference><Citation>Siqueiros-Cend&#xf3;n T., Ar&#xe9;valo-Gallegos S., Iglesias-Figueroa B.F., Garc&#xed;a-Montoya I.A., Salazar-Mart&#xed;nez J., Rasc&#xf3;n-Cruz Q. Immunomodulatory effects of lactoferrin. Acta Pharmacol. Sin. 2014;35:557&#x2013;566. doi: 10.1038/aps.2013.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2013.200</ArticleId><ArticleId IdType="pmc">PMC4814036</ArticleId><ArticleId IdType="pubmed">24786230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwirzitz A., Reiter M., Skrabana R., Ohradanova-Repic A., Majdic O., Gutekova M., Cehlar O., Petrov&#x10d;&#xed;kov&#xe1; E., Kutejova E., Stanek G., et al. Lactoferrin is a natural inhibitor of plasminogen activation. J. Biol. Chem. 2018;293:8600&#x2013;8613. doi: 10.1074/jbc.RA118.003145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003145</ArticleId><ArticleId IdType="pmc">PMC5986228</ArticleId><ArticleId IdType="pubmed">29669808</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione E., Lanna C., Cosio T., Rosa L., Conte M.P., Iacovelli F., Romeo A., Falconi M., Del Vecchio C., Franchin E., et al. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. Front. Pharmacol. 2021;12:666600. doi: 10.3389/fphar.2021.666600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.666600</ArticleId><ArticleId IdType="pmc">PMC8242182</ArticleId><ArticleId IdType="pubmed">34220505</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaris C., Scarpa M., Elli M., Bertolini A., Guglielmetti S., Pregliasco F., Blandizzi C., Brun P., Castagliuolo I. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro. Nutrients. 2021;13:328. doi: 10.3390/nu13020328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020328</ArticleId><ArticleId IdType="pmc">PMC7911668</ArticleId><ArticleId IdType="pubmed">33498631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Meng X., Zhang F., Xiang Y., Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg. Microbes Infect. 2021;10:317&#x2013;330. doi: 10.1080/22221751.2021.1888660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1888660</ArticleId><ArticleId IdType="pmc">PMC7919907</ArticleId><ArticleId IdType="pubmed">33560940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Heyden E.L., Pretorius E. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front. Immunol. 2020;11:1221. doi: 10.3389/fimmu.2020.01221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Ng T.B., Sun W.Z. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int. J. Antimicrob. Agents. 2020;56:106118. doi: 10.1016/j.ijantimicag.2020.106118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106118</ArticleId><ArticleId IdType="pmc">PMC7390755</ArticleId><ArticleId IdType="pubmed">32738305</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione E., Lanna C., Cosio T., Rosa L., Conte M.P., Iacovelli F., Romeo A., Falconi M., Del Vecchio C., Franchin E., et al. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int. J. Environ. Res. Public Health. 2021;18:10985. doi: 10.3390/ijerph182010985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010985</ArticleId><ArticleId IdType="pmc">PMC8535893</ArticleId><ArticleId IdType="pubmed">34682731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93:250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad J., Martin J.C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;10:102&#x2013;108. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Cardona A., Lloreta Trull J., Albero-Gonz&#xe1;lez R., Paraira Beser M., And&#xfa;jar X., Ruiz-Ramirez P., Tur-Mart&#xed;nez J., Ferrer C., De Marcos Izquierdo J.A., P&#xe9;rez-Madrigal A., et al. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: Two case reports. BMC Gastroenterol. 2021;21:334. doi: 10.1186/s12876-021-01905-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-021-01905-3</ArticleId><ArticleId IdType="pmc">PMC8390036</ArticleId><ArticleId IdType="pubmed">34445965</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz V.A., Assis A.M., da Costa R., J&#xfa;nior H. Protective effect of human lactoferrin in the gastrointestinal tract. Rev. Paul. Pediatr. 2013;31:90&#x2013;95. doi: 10.1590/S0103-05822013000100015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0103-05822013000100015</ArticleId><ArticleId IdType="pubmed">23703050</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Jiang R., L&#xf6;nnerdal B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochem. Cell Biol. 2012;90:476&#x2013;484. doi: 10.1139/o11-075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/o11-075</ArticleId><ArticleId IdType="pubmed">22332905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega-Bautista A., de la Garza M., Carrero J.C., Campos-Rodr&#xed;guez R., God&#xed;nez-Victoria M., Drago-Serrano M.E. The Impact of Lactoferrin on the Growth of Intestinal Inhabitant Bacteria. Int. J. Mol. Sci. 2019;20:4707. doi: 10.3390/ijms20194707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20194707</ArticleId><ArticleId IdType="pmc">PMC6801499</ArticleId><ArticleId IdType="pubmed">31547574</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffan A.M., McKenzie R., Forti J., Conklin D., Marcinko R., Shrestha R., Bellantoni M., Greenough W.B., III Lactoferrin for the prevention of post-antibiotic diarrhoea. J. Health Popul. Nutr. 2011;29:547&#x2013;551. doi: 10.3329/jhpn.v29i6.9889.</Citation><ArticleIdList><ArticleId IdType="doi">10.3329/jhpn.v29i6.9889</ArticleId><ArticleId IdType="pmc">PMC3259716</ArticleId><ArticleId IdType="pubmed">22283027</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Martinez A.M., Exp&#xf3;sito-Herrera J., Gonzalez-Bol&#xed;var M., Fern&#xe1;ndez-Marin E., Uberos J. Evaluation of Risk and Preventive Factors for Necrotizing Enterocolitis in Premature Newborns. A Systematic Review of the Literature. Front. Pediatr. 2022;10:874976. doi: 10.3389/fped.2022.874976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.874976</ArticleId><ArticleId IdType="pmc">PMC9152085</ArticleId><ArticleId IdType="pubmed">35656377</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico F., Decembrino N., Muratore E., Turroni S., Muggeo P., Mura R., Perruccio K., Vitale V., Zecca M., Prete A., et al. Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies. Pharmaceutics. 2022;14:1705. doi: 10.3390/pharmaceutics14081705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14081705</ArticleId><ArticleId IdType="pmc">PMC9416448</ArticleId><ArticleId IdType="pubmed">36015331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43:268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F., Di Giuda D., Morello R., De Rose C., Valentini P., Buonsenso D. Orbito-Frontal Cortex Hypometabolism in Children with Post-COVID Condition (Long COVID): A Preliminary Experience. Pediatr. Infect. Dis. J. 2022;41:663&#x2013;665. doi: 10.1097/INF.0000000000003578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003578</ArticleId><ArticleId IdType="pmc">PMC9281418</ArticleId><ArticleId IdType="pubmed">35839175</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Giuda D., Sigfrid L., Pizzuto D.A., Di Sante G., De Rose C., Lazzareschi I., Sali M., Baldi F., Chieffo D.P.R., et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child. Adolesc. Health. 2021;5:677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Martino L., Morello R., De Rose C., Valentini P. Chronic Olfactory Dysfunction in Children with Long COVID: A Retrospective Study. Children. 2022;9:1251. doi: 10.3390/children9081251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9081251</ArticleId><ArticleId IdType="pmc">PMC9406427</ArticleId><ArticleId IdType="pubmed">36010141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>